CT

Chinook Therapeutics

Acquired

Seattle, United States · Founded 2019 · $171.0M raised

Founded
2019
Business Model
B2B
Total Funding
$171.0M
Last Round
$106.0M Series BAug 2020
Rounds
2
Acquired by
Novartis AGMay 2023 · $3.2B

About

Chinook Therapeutics was a Seattle-based clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for kidney diseases. Its pipeline included two late-stage IgA nephropathy assets, atrasentan, an oral endothelin A receptor antagonist, and zigakibart (BION-1301), an anti-APRIL monoclonal antibody, plus earlier-stage research programs. Founded in 2019, Chinook was acquired by Novartis in August 2023 in a transaction valued at up to USD 3.5 billion.

Summary

Chinook Therapeutics is a Biotech company based in Seattle, United States, founded in 2019. It has raised $171.0M in total across 2 rounds, most recently a $106.0M Series B round in Aug 2020. Investors include Versant Ventures, Novartis Venture Fund and EcoR1 Capital.

Funding History

AcquisitionMay 2023

Sign up to see all 3 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Chinook Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/chinook-therapeutics"><img src="https://indexed.vc/api/badge/company/chinook-therapeutics" alt="Chinook Therapeutics on Indexed.vc" width="260" height="76" /></a>